Mylan Plans To Compete In US HIV Market With Two Fixed-Dose Combos
Generics firm will launch single-tablet regimens of older HIV drugs not otherwise available as combos in US, with discounted pricing.
Generics firm will launch single-tablet regimens of older HIV drugs not otherwise available as combos in US, with discounted pricing.